Asia-Pacific and Personalised Medicine: Predictive, Preventive, Participatory, Personalised, and Pre-emptive (5Ps) Health Systems in Asia-Pacific
Moderator: Einstein Rojas, Board Member, Philippine Alliance of Patient Organizations (PAPO)
Kawaldip Sehmi, CEO, International Alliance of Patients’ Organizations (IAPO)
Farid Bidgoli, General Manager, Roche Thailand, Myanmar, Cambodia and Laos
Dr Arshiya Zaheer, Patient Engagement Lead - Japan, China and Asia Pacific, MSD
Dr Ugyen Tshomo, Obstetrician-gynecologist & Co-founder and Board Member of Bhutan Cancer Society
This session looks at genomic medicine and its various applications within the Asia-Pacific Health Systems. The terminology currently used needs to be standardised in the AP region so that we all are talking about the same health technologies and applications.
We now have innovative health technologies at our disposal that can help our health systems to become predictive, preventative, participatory, personalised, and pre-emptive (5ps).
These 5Ps within the AP Region can improve:
Patient health outcomes;
Patient experience;
Meet/Matching patient preferences;
Health system effectiveness, efficiency, safety, acceptability, and accessibility whilst delivering quality healthcare in a compassionate and humanistic way.
These health technologies have their greatest application in NCD control and care. We can transform and personalise the way in which, and how fast, NCDs are screened, diagnosed, and treated without disrupting lives and families.
Personalised Medicine aims to give the right treatment to the right patient at the right time. This gives us better outcomes and improves patient safety, particularly reducing the risk of adverse events.
